NicOx

Contact
nicox.com
+33497245300

NicOx S.A.

Les Taissounières - 1681 Route des Dolines - Bat HB4
06 906 Sophia Antipolis
France
+33497245300
nicox.com
Contact
Profile Products News
Contact

About NicOx

Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world.

Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform.

Read more about NicOx
Facts about NicOx
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of NicOx

Product portfolio

Show all

News about NicOx

NicOx

14-Jan-2010 | business & finance

NicOx and TOPIGEN Pharmaceuticals terminate collaboration following the acquisition of TOPIGEN by Pharmaxis

NicOx S.A. announced that NicOx and TOPIGEN Pharmaceuticals Inc. have mutually terminated their collaboration for TPI 1020. This decision was made as a ...

Read news
NicOx

23-Dec-2009 | business & finance

NicOx successfully completes its right issue, raising €100 million following a two-step capital increase

NicOx S.A. announced that it has raised a total of approximately €100 million via a two-step capital increase. The second step of this capital increase was ...

Read news
NicOx

23-Dec-2009 | research and development

NicOx submits naproxcinod MAA to the EMEA

NicOx S.A. announced that a Marketing Authorization Application (MAA) for naproxcinod has been submitted to the European Medicines Agency (EMEA) through ...

Read news
NicOx

16-Nov-2009 | research and development

NicOx announces NCX 6560 meets primary and secondary objectives in first-in-man study

NicOx S.A. announced that a phase 1b, first-in-man study for NCX 6560, versus placebo and Lipitor® (atorvastatin), has met its primary and secondary ...

Read news
NicOx

06-Aug-2009 | business & finance

NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer

NicOx S.A. announced the signature of an agreement with Pfizer Inc to reacquire the full development and commercialization rights to PF-03187207, which has ...

Read news
NicOx

24-Apr-2009 | research and development

NicOx acquires Nitromed’s NO-donating patents

NicOx S.A. announced it has agreed to purchase Nitromed’s unlicensed patent estate covering nitric oxide-donating compounds. According to the company, this ...

Read news
NicOx

20-Mar-2009 | research and development

NicOx initiates proof-of-principle clinical study for NCX 6560

First-in-man study for an innovative investigational drug, representing a global therapeutic approach for reduction of cardiovascular risk

Read news
NicOx

03-Dec-2008 | business & finance

NicOx signs agreement with DSM for the commercial manufacture of naproxcinod drug substance

NicOx S.A. announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active ...

Read news
Show more news about NicOx

Here you will find NicOx S.A.